Immunovant, Inc. IMVT Bermuda — Total loss before income taxes

Other geography segments

Similar metrics at other companies

EXPPre-Tax Income (Domestic)

$78.4M-3.2%

ZIONCB&T — Income (loss) before income taxes

$88M+33.3%

PNCIncome (Loss) from Continuing Operations Before Income Taxes, Domestic

$2.09B+19.1%

CRLIncome (Loss), Including Portion Attributable to Noncontrolling Interest, before Tax

-$29.94M-183%

RCLIncome (Loss) from Continuing Operations Before Income Taxes, Domestic

$852.75M+41.1%

IQVIncome Loss From Continuing Operations After Income Taxes And Before Equity In Earnings Of Unconsolidated Affiliates

$269M+2.7%

Questions, answered.

What is Immunovant, Inc.'s bermuda — total loss before income taxes?

Immunovant, Inc. (IMVT) reported bermuda — total loss before income taxes of -$9.75K in Q1 2026.

How has Immunovant, Inc.'s bermuda — total loss before income taxes changed year-over-year?

Immunovant, Inc.'s bermuda — total loss before income taxes increased by 61.0% year-over-year, from -$25K to -$9.75K.

What is the long-term trend for Immunovant, Inc.'s bermuda — total loss before income taxes?

Over 4 years (2022 to 2026), Immunovant, Inc.'s bermuda — total loss before income taxes has grown at a -15.6% compound annual growth rate (CAGR), from -$77K to -$39K.

What does bermuda — total loss before income taxes mean?

This metric represents the total pre-tax financial loss attributable to the company's Bermuda-based operations. It reflects the net impact of operating expenses and income generated within this specific geographic segment before accounting for income tax provisions. Monitoring this figure helps investors assess the operational burn rate and financial performance of the entity's offshore or holding company structure.